This issue covers the latest developments in the understanding of rheumatoid arthritis at the early stage. Treatments such as with newer biologic agents and conventional disease-modifying antirheumatic drugs are reviewed. Also included are articles on imaging modalities as a means of identifying those in the early stages and monitoring response to treatment.
1. The Evidence of Early Intervention (Quinn) 2. Encouraging Early Referral to Rheumatologists (Cush) 3. Early Arthritis Cohorts (Silman and Symmons) 4. Early Undifferentiated Arthritis (El-Gabalawy) 5. Early Oligoarthritis (Green and Marzo-Ortega) 6. Early Psoriatic Arthritis (Kane) 7. Early Rheumatoid Arthritis (Young) 8. MR/US as Diagnostic Tool in Early Arthritis (Wakefield and Conghan) 9. Value of DXA as Diagnostic and Assessment Tool in Early Arthritis (Haugeberg) 10. Radiology in Early Arthritis (Heijde) 11. Conventional DMARDS in Early Arthritis (Mottonen) 12. Biologics in Early Arthritis (Breedveld) 13. Potential for Altering RA Outcome (Quinn)
Comments (0)
Your review appreciation cannot be sent
Report comment
Are you sure that you want to report this comment?
Report sent
Your report has been submitted and will be considered by a moderator.